v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net earnings/(loss) $ 2,678 $ 2,462
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:    
Depreciation and amortization, net 594 1,012
Deferred income taxes 161 223
Stock-based compensation 146 144
Impairment charges 412 5
Divestiture gains and royalties (34) (292)
Acquired IPRD 94 188
Equity investment (gains)/losses, net (134) 78
Other adjustments 21 5
Changes in operating assets and liabilities:    
Receivables 1,687 15
Inventories 14 (169)
Accounts payable 409 (85)
Rebates and discounts (3,495) (627)
Income taxes payable 187 54
Other (1,636) (1,059)
Net cash provided by operating activities 1,104 1,954
Cash Flows From Investing Activities:    
Sale and maturities of marketable debt securities 359 220
Purchase of marketable debt securities (781) (636)
Proceeds from sales of equity investments 391 12
Capital expenditures (347) (260)
Divestiture and other proceeds 312 243
Acquisition and other payments, net of cash acquired (65) (78)
Net cash provided by/(used in) investing activities (131) (499)
Cash Flows From Financing Activities:    
Other short-term financing obligations, net 321 368
Repayments of long-term debt (500) 0
Dividends (1,283) (1,258)
Stock option proceeds and other, net (98) (103)
Net cash provided by/(used in) financing activities (1,560) (993)
Effect of exchange rates on cash, cash equivalents and restricted cash (48) 66
Increase/(decrease) in cash, cash equivalents and restricted cash (635) 528
Cash, cash equivalents and restricted cash at beginning of period 10,218 10,347
Cash, cash equivalents and restricted cash at end of period $ 9,583 $ 10,875